SeaStar Medical (ICU) Stock Price, News & Analysis

Company Overview

SeaStar Medical is a medical device company focused on the design, development and commercialization of minimally invasive surgical access systems. The company’s product platforms aim to improve patient outcomes in transcatheter heart valve replacement and repair procedures by offering precise, low-profile access to vascular structures. SeaStar Medical’s devices are engineered to streamline procedural workflows and reduce complication rates associated with large-bore arterial punctures.

The flagship offering is the SPIDER Micro-Invasive Transcatheter Aortic Valve Replacement (TAVR) Access System, designed to facilitate controlled, hemostatic entry and closure during valve replacement procedures. In addition, the company markets the S-Access Micro-Puncture Kits, which include 18- and 22-gauge needle sets and specialty sheaths to support a broad range of diagnostic and interventional cardiology and endovascular therapies. These platforms are cleared by the U.S. Food and Drug Administration and carry CE mark approval for commercial distribution in Europe.

SeaStar Medical serves hospitals and cardiovascular centers across North America and select international markets through a combination of direct sales and distributor partnerships. The company’s offerings are used in high-volume structural heart programs as well as catheterization laboratories pursuing next-generation percutaneous interventions. In parallel, SeaStar continues to advance its pipeline of access and closure technologies for mitral and tricuspid valve repair procedures, reflecting its commitment to addressing growing clinical need in structural heart disease.

Founded in 2007 and headquartered in Morrisville, North Carolina, SeaStar Medical was built on the vision of improving procedural safety in minimally invasive cardiovascular interventions. The company’s leadership team comprises seasoned medical device executives and clinical advisors with extensive experience at leading cardiovascular technology firms. This expertise underpins SeaStar Medical’s focus on innovation, quality manufacturing and strategic market expansion.

Key Stats

• Today's Range: $0.54 to $0.62
• 50-Day Range: $0.33 to $1.30
• 52-Week Range: $0.31 to $9.56
• Volume: 2.89 million shs
• Average Volume: 1.76 million shs
• Market Capitalization: $6.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SeaStar Medical Stock Analysis - MarketRank™

SeaStar Medical scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for SeaStar Medical.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of SeaStar Medical is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of SeaStar Medical is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

19.11% of the float of SeaStar Medical has been sold short.

Short Interest Ratio / Days to Cover

SeaStar Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SeaStar Medical has recently increased by 3,606.03%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SeaStar Medical does not currently pay a dividend.

Dividend Growth

SeaStar Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

19.11% of the float of SeaStar Medical has been sold short.

Short Interest Ratio / Days to Cover

SeaStar Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SeaStar Medical has recently increased by 3,606.03%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: -0.01

News Sentiment

SeaStar Medical has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for SeaStar Medical this week, compared to 4 articles on an average week.

Search Interest

8 people have searched for ICU on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added SeaStar Medical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, SeaStar Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $37,025.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 1.30% of the stock of SeaStar Medical is held by insiders.

Percentage Held by Institutions

Only 1.69% of the stock of SeaStar Medical is held by institutions.

ICU Stock Analysis - Frequently Asked Questions

How have ICU shares performed this year?

SeaStar Medical's stock was trading at $1.94 at the beginning of 2025. Since then, ICU shares have decreased by 71.2% and is now trading at $0.5580.

How were SeaStar Medical's earnings last quarter?

SeaStar Medical Holding Corporation (NASDAQ:ICU) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.44) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.52) by $0.08. The firm had revenue of $0.29 million for the quarter, compared to the consensus estimate of $0.15 million.
Read the conference call transcript.

When did SeaStar Medical's stock split?

SeaStar Medical's stock reverse split on the morning of Monday, June 10th 2024.The 1-25 reverse split was announced on Monday, June 10th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of SeaStar Medical?

Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SeaStar Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaStar Medical investors own include Meta Platforms (META), Pfizer (PFE), Energy Transfer (ET), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and Visa (V).

Company Calendar

• Last Earnings: 5/14/2025
• Today: 7/16/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:ICU
• CIK: 1831868
• Web: seastarmedical.com
• Phone: 844-427-8100
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($3.47)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$24.83 million
• Net Margins: N/A
• Pretax Margin: -3,714.72%
• Return on Equity: N/A
• Return on Assets: -313.28%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.96
• Quick Ratio: 0.96

Sales & Book Value

• Annual Sales: $140 thousand
• Price / Sales: 44.64
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.34) per share
• Price / Book: -1.64

Miscellaneous

• Outstanding Shares: 11,200,000
• Free Float: 11,058,000
• Market Cap: $6.25 million
• Optionable: Not Optionable
• Beta: -1.09